HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Role of debridement and interferon in the treatment of dendritic keratitis.

Abstract
In a controlled clinical study, 42 patients with dendritic keratitis were treated either with thermocautery plus human leukocyte interferon (HLI) or with minimal wiping debridement plus HLI. The results show that the efficiency with which primary debridement was carried out, determined the success of further therapy using interferon. We conclude that interferon works basically as a prophylactic agent and needs the support of further antiviral measures to be effective against dendritic keratitis.
AuthorsR Sundmacher, K Cantell, P Haug, D Neumann-Haefelin
JournalAlbrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie. Albrecht von Graefe's archive for clinical and experimental ophthalmology (Albrecht Von Graefes Arch Klin Exp Ophthalmol) Vol. 207 Issue 2 Pg. 77-82 (Jul 17 1978) ISSN: 0065-6100 [Print] Germany
PMID308783 (Publication Type: Journal Article)
Chemical References
  • Interferons
Topics
  • Debridement
  • Electrocoagulation
  • Humans
  • Interferons (therapeutic use)
  • Keratitis, Dendritic (drug therapy, surgery, therapy)
  • Leukocytes

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: